Healthcare -
Biotechnology - NASDAQ - US
$ 1.54
0 %
$ 4.63 M
Market Cap
-0.14
P/E
SONN - GROSS PROFIT
Gross Profit SONN - Sonnet BioTherapeutics Holdings, Inc.
18.6 K
LAST VALUE
-73.06%
2 YEAR CAGR
-77.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR